Rubello D, Busnardo B, Girelli M E, Piccolo M
Istituto di Semeiotica Medica, Università di Padova, Italy.
J Endocrinol Invest. 1989 Sep;12(8):571-5. doi: 10.1007/BF03350763.
A case is reported of neoplastic TSH hypersecretion in a 62-year-old man with severe hyperthyroidism and cardiovascular disease. He had been known to be hyperthyroid for 14 yr, and had been treated by thyreostatic drugs and subtotal thyroidectomy without satisfactory results. When he was referred to our Center, he was frankly hyperthyroid with both TSH (14 microU/ml) and thyroid hormone serum levels (TT4 24 micrograms/dl, TT3 370 ng/dl, FT41 7.9) above the normal range. alpha-subunit serum level was markedly increased (7.2 ng/ml), while beta-subunit was only 0.3 ng/ml. Skull X-ray showed an enlarged sella turcica with destruction of the dorsum and an intrasellar tumor was visualized on conventional and computer tomography. TSH response was absent after TRH and domperidone, while TSH serum levels decreased by 25% after bromocriptine. Methimazole therapy temporarily decreased serum thyroid hormones to normal levels, while TSH levels rose to 34 microU/ml, thus indicating that pituitary-thyroid feed-back was maintained at a higher set point. Surgical attempt failed because of cardiac problems during anesthesia. Radiotherapy plus methimazole was begun and TSH serum levels first increased markedly, up to 140 microU/ml, and then progressively decreased without reaching normal values. After methimazole withdrawal hyperthyroidism recurred.
报告一例62岁患有严重甲状腺功能亢进和心血管疾病的男性肿瘤性促甲状腺激素分泌过多的病例。他被诊断为甲状腺功能亢进已有14年,曾接受过抗甲状腺药物和甲状腺次全切除术治疗,但效果不佳。当他被转诊到我们中心时,明显处于甲状腺功能亢进状态,促甲状腺激素(TSH,14微单位/毫升)和甲状腺激素血清水平(总甲状腺素TT4 24微克/分升,总三碘甲状腺原氨酸TT3 370纳克/分升,游离甲状腺素指数FT4I 7.9)均高于正常范围。血清α亚基水平显著升高(7.2纳克/毫升),而β亚基仅为0.3纳克/毫升。颅骨X线显示蝶鞍扩大,鞍背破坏,常规和计算机断层扫描可见鞍内肿瘤。促甲状腺激素释放激素(TRH)和多潘立酮刺激后促甲状腺激素无反应,而溴隐亭治疗后促甲状腺激素血清水平下降25%。甲巯咪唑治疗可使血清甲状腺激素暂时降至正常水平,而促甲状腺激素水平升至34微单位/毫升,这表明垂体-甲状腺反馈维持在较高设定点。由于麻醉期间出现心脏问题,手术尝试失败。开始进行放疗加甲巯咪唑治疗,促甲状腺激素血清水平首先显著升高,高达140微单位/毫升,然后逐渐下降,但未达到正常水平。停用甲巯咪唑后,甲状腺功能亢进复发。